ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$0.12
-0.02 (-15.69%)
As of May 1, 7:15 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +29,350.8% upside
Low Target $28.98
Average Target $35.93
High Target $50.96
Current Price $0.12
Current
$0.12
Target
$35.93
$28.98 $35.93 avg $50.96
Scenario Analysis
Bear Case
$28.98
23,654.1%
Low target
Base Case
$35.93
+29,350.8%
Avg target
Bull Case
$50.96
+41,670.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$35.93
+163.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%